The University of Chicago Medical Center, Chicago, Illinois.
Optom Vis Sci. 2021 Apr 1;98(4):418-424. doi: 10.1097/OPX.0000000000001670.
Although von Willebrand disease is the most common inherited bleeding disorder, there are only a few published reports of ocular complications. To our knowledge, this is the first case of peripheral retinal ischemia and retinal neovascularization in a patient with von Willebrand disease.
This study aimed to demonstrate the value of multispecialty care when exploring a diagnosis for bilateral retinopathy.
A 55-year-old African American woman presented with peripheral retinal hemorrhages on routine examination. She was asymptomatic and did not have any personal or family history of bleeding disorders. Blood work was ordered, and she was referred to a retinal specialist who found peripheral telangiectasia, retinal ischemia, and leakage on fluorescein angiography, consistent with retinal neovascularization. Laser photocoagulation was performed while numerous specialists were consulted to determine the cause for her retinopathy. Laboratory testing confirmed low-grade type 1 von Willebrand disease. She was monitored without systemic treatment. She remained stable and asymptomatic, but her retinal neovascularization did not regress fully, so laser treatment was repeated.
This case described a new finding of peripheral retinal ischemia and retinal neovascularization in von Willebrand disease. It was discovered in an asymptomatic patient who did not have a history of bleeding but presented with bilateral retinal hemorrhages. Diagnosis was challenging because of the high degree of variation in this bleeding disorder, requiring extensive testing and careful consideration of the individual's clinical profile. Most people with von Willebrand disease do not know they have the disease because symptoms are mild or absent, so most cases are unreported. The von Willebrand factor is poorly recognized in ocular disease, but given its role in angiogenesis, it may be a valuable target to consider in future research.
尽管血管性血友病是最常见的遗传性出血性疾病,但仅有少数关于眼部并发症的报道。据我们所知,这是首例血管性血友病患者出现周边视网膜缺血和视网膜新生血管的病例。
本研究旨在展示多学科治疗在探索诊断双侧视网膜病变中的价值。
一名 55 岁非裔美国女性在常规检查时出现周边视网膜出血。她无症状,无出血性疾病个人或家族史。进行了血液检查,并将其转介给视网膜专家,发现周边毛细血管扩张、视网膜缺血和荧光素血管造影中的渗漏,符合视网膜新生血管的表现。进行了激光光凝治疗,同时咨询了许多专家以确定她视网膜病变的原因。实验室检测证实为低级别 1 型血管性血友病。她未接受系统治疗而被监测。她保持稳定且无症状,但视网膜新生血管未完全消退,因此重复进行激光治疗。
本病例描述了血管性血友病中一种新的发现,即周边视网膜缺血和视网膜新生血管。它发生在一位无症状的患者中,该患者无出血史,但表现为双侧视网膜出血。由于这种出血性疾病的变异性很高,诊断具有挑战性,需要进行广泛的检测,并仔细考虑个体的临床特征。大多数血管性血友病患者不知道自己患有该疾病,因为症状较轻或不存在,因此大多数病例未被报道。血管性血友病因子在眼部疾病中未得到充分认识,但鉴于其在血管生成中的作用,它可能是未来研究中值得考虑的一个有价值的靶点。